NBIX vs UBCP · P/E 45, rev $1.77B vs P/E 12, rev $20.5M
Neurocrine Biosciences Inc (NBIX) versus United Bancorp Inc (UBCP) — a side-by-side from cached financials, not a winner call.
Neurocrine Biosciences Inc (NBIX) is a drug manufacturers - specialty & generic company listed on US.
United Bancorp Inc (UBCP) is a banks - regional company listed on US.
Latest reported NBIX revenue for 2026-06-30 was $1.77B. Net income was $342.3M. NBIX currently screens at market cap $13.21B and trailing P/E 45.2.
Latest reported UBCP revenue for 2026-06-30 was $20.5M. Net income was $4.0M. UBCP currently screens at market cap $82.6M and trailing P/E 11.5.
NBIX currently screens at market cap $13.21B and trailing P/E 45.2. UBCP currently screens at market cap $82.6M and trailing P/E 11.5.
Not investment advice. Open the NBIX and UBCP stock pages for the full models.
Not investment advice.